Abstract
Human Protein C (HPC), an antithrombotic factor with potential clinical utility, is a vitamin K-dependent protein that has several complex post-translational modifications. In an effort to define the functional roles of these modifications, recombinant HPC (rHPC) was expressed in and characterized from 3 adenovirus-transformed cell lines. The rHPC in crude culture medium from the 3 cell lines displayed anticoagulant activities that were either higher, slightly lower or much lower than that of plasma HPC. The rHPC from each cell line was purified and characterized using a novel, but simple chromatographic method, termed “pseudo-affinity”, capable of resolving molecules differing by only very slight modifications. We demonstrate the critical dependence of full γ-carboxylation on the function of this protein. In addition, our data indicate that both the γ-carboxyglutamate and glycosyl contents affect the functional activities of rHPC.
Similar content being viewed by others
References
Esmon, C.T. 1989. The role of Protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264: 4743–4746.
Stenflo, J. 1988. The biochemistry of Protein C, p. 21–53. In: Protein C and Related Proteins. Bertina, R. M. (Ed.). Churchill Livingstone, New York.
Suttie, J.W. 1986. Report of workshop on expression of vitamin K- dependent proteins in bacterial and mammalian cells. Thrombosis Res. 44: 129–134.
Foster, D.C., Rudinski, M.S., Schach, B.G., Berkner, K.L., Kumar, A.A., Hagen, F.S., Sprecher, C.A., Insley, M.Y. and Davie, E.W. 1987. Propeptide of human Protein C is necessary for gamma-carboxylation. Biochem. 26: 7003–7011.
Suttie, J.W., Hoskins, J.A., Engelke, J., Hopfgartner, A., Ehrlich, H., Bang, N.U. Belagaje, R.M., Schoner, B. and Long, G.L. 1987. Vitamin K-dependent carboxylase: possible role of the substrate “Propeptide” as an intracellular recognition site. Proc. Natl. Acad. Sci. USA 84: 634–637.
Stenflo, J., Holme, E., Lindstedt, S., Chandramouli, N., Tsai-Huang, L.H., Tam, J.P. and Merrifield, R.B. 1989. Hydroxylation of aspartic acid in domains homologous to the epidermal growth factor precursor is catalysed by a 2-oxoglutarate-dependent dioxygenase. Proc. Natl. Acad. Sci. USA 86: 444–447.
Derian, C.K., VanDusen, W., Prysiecki, C.T., Walsh, P.N., Berkner, K.L., Kaufman, R.J. and Friedman, P.A. 1989. Inhibitors of 2-ketoglutarate-deendent dioxygenase block aspartyl beta-hydroxylation of recombinant human Factor IX in several mammalian expression system. J. Biol. chem. 264: 6615–6618.
Gronke, R.S., VanDusen, W.J., Garsky, V.M., Jacobs, J.W., Sardana, M.K., Stern, A.M. and Friedman, P.A. 1989. Aspartyl-beta-hydroxylase: In vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IX. Proc. Natl. Acad. Sci. USA 86: 3609–3613.
Ohlin, A., Landes, G., Bourdon, P., Oppenheimer, C., Wydro, R. and Stenflo, J. 1988. Beta-hydroxyaspartic acid in the first epidermal growth factor-like domain of Protein C. J. Biol. Chem. 263: 19240–19248.
Rees, D.J.G., Jones, I.M., Handford, P.A., Walter, S.J., Esnouf, M.P. Smith, K.J. and Brownlee, G.G. 1988. The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human Factor IX. EMBO J. 7: 2053–2061.
Stenflo, J. and Fernlund, P. 1982. Amino acid sequence of the heavy chain of bovine Protein C. J. Biol. chem. 257: 12180–12190.
Titani, K., Kumar, S., Takio, K., Ericsson, L.H., Wade, R.D., Ashida, K., Walsh, K.A., Chopek, M.W., Sadler, J.E. and Fujikawa, K. 1986. Amino acid sequence of human von Willebrand Factor. Biochem. 25: 3171–3184.
Yan, S.C., Grinnell, B.W. and Wold, F. 1989. Posttranslational modifications of proteins: some problems left to solve. Trends in Biological Sci. 14: 264–268.
Grinnell, B.W., Berg, D.T., Walls, J. and Yan, S.B. 1987. Transactivated expression of fully gamma-carboxylated recombinant human Protein C, an antithrombotic factor. Bio/Technology 5: 1189–1192.
Berg, D.T., Walls, J.D. and Grinnell, B.W. 1988. A variant enhancer/regulatory region from a cloned human prototype BK virus genome. Nuc. Acids Res. 16: 9057.
Beckman, R.J., Schmidt, R.J., Santerre, R.F., Plutzky, J., Crabtree, G.R. and Long, G.L. 1985. The structure and evolution of a 461 amino acid human Protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs. Nuc. Acids Res. 13: 5233–5247.
Grinnell, B.W., Berg, D.T. and Walls, J. 1986. Activation of the adenovirus and BK virus late promotors: Effects of the BK virus enhancer and trans-acting viral early proteins. Mol. Cell. Biol. 6: 3596–3605.
Kuwada, M. and Katayama, K. 1983. An improved method for the determination of gamma-carboxyglutamic acid in proteins, bone and urine. Anal. Biochem. 131: 173–179.
Alvarez-Coque, M.C.G., Hernandez, M.J.M., Camanas, R.M.V. and Fernandez, C.M. 1989. Formation and instability of o-phthalaldehyde derivatives of amino acids. Anal. Biochem. 178: 1–7.
de Monitgny, P., Stobaugh, J.F., Givens, R.S., Carlson, R.G., Srinivasachar, K., Sternson, L.A. and Higuchi, T. 1987. Reversed-phase HPLC separation of dimethylaminoazobenzene sulfonyl and dimethylaminoazobenzene thiohydantoin-amino acid derivatives for amino acid analysis and microsequencing studies at the pmole level. Anal. Chem. 59: 1096–1101.
Hardy, M.R., Townsend, R.R. and Lee, Y.C. 1988. Monosaccharide analysis of glycoconjugates by anion exchange chromatography with pulsed amperometric detection. Anal. Biochem. 170: 54–62.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.
Bradford, M. 1976. A rapid and sensitive methhod for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248–254.
Stenflo, J. 1976. A new vitamin K-dependent protein. J. Biol. Chem. 251: 355–363.
Johnson, A.E., Esmon, N.L., Laue, T.M. and Esmon, C.T. 1983. Structural changes required for activation of protein C are induced by Ca2+ binding to a high affinity site that does not contain gamma-carboxyglutamic acid. J. Biol. Chem. 258: 5554–5560.
Kisiel, W. and Davie, E.W. 1981. Protein C. Meth. Enzymol. 80: 320–332.
Borowski, M., Furie, B.C., Goldsmith, G.H. and Furie, B. 1985. Metal and phospholipid binding properties of partially carboxylated human prothrombin variants. J. Biol. Chem. 260: 9258–9264.
Fernlund, P. and Stenflo, J. 1982. Amino acid sequence of the light chain of bovine Protein C. J. Biol. Chem. 257: 12170–12179.
Green, E.D. and Baenziger, J.U. 1988. Asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin. J. Biol. Chem. 263: 25–35.
Defize, L.H.K., Arndl-Jovin, D.J., Jovin, T.M., Boonstra, J., Meisenhelder, J., Hunter, T., de Hey, H.T. and de Laat, S.W. 1988. A 431 cell variants lacking the blood group A antigen display increased high affinity epidermal growth factor-receptor number, protein-tyrosine kinase activity, and receptor turnover. J. Cell Biol. 107: 939–949.
Miletich, J.P. and Broze, G.J. 1988. Human beta-Protein C is not glycosylated at the fourth N-linked site. Blood 72: 371a.
Hau, L. and Salem, H.H. 1988. The effect of enzymatic removal of sialic acids on the functional properties of Protein C. Thrombosis & Haemostasis 60: 267–270.
Kaufman, R.J., Wasley, L.C., Furie, B.C., Furie, B. and Shoemaker, C.B. 1986. Expression, purification and characterization of recombinant gamma-carboxylated Factor IX synthesized in Chinese hamster ovary cells. J. Biol. Chem. 261: 9622–9628.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yan, S., Razzano, P., Chao, Y. et al. Characterization and Novel Purification of Recombinant Human Protein C from Three Mammalian Cell Lines. Nat Biotechnol 8, 655–661 (1990). https://doi.org/10.1038/nbt0790-655
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0790-655
- Springer Nature America, Inc.